[HTML][HTML] Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial

…, C Nyanou, C Montlahuc, L Biard… - JAMA internal …, 2021 - jamanetwork.com
Importance Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common
presentation of coronavirus disease 2019 (COVID-19). Objective To determine whether …

[HTML][HTML] Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

…, C Nyanou, C Montlahuc, L Biard… - The Lancet …, 2021 - thelancet.com
Background Patients with COVID-19 pneumonia have an excess of inflammation and
increased concentrations of cytokines including interleukin-1 (IL-1). We aimed to determine …

Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients

C Comarmond, L Biard, M Lambert, A Mekinian… - Circulation, 2017 - Am Heart Assoc
Background: Because of the wide variation in the course of Takayasu arteritis (TA), predicting
outcome is challenging. We assess long-term outcome and prognosis factors for vascular …

Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma

…, H Roussel, M Mandavit, P Ravel, M Sibony, L Biard… - Cancer research, 2017 - AACR
Inhibitory receptors expressed by T cells mediate tolerance to tumor antigens, with coexpression
of these receptors exacerbating this dysfunctional state. Using the VectraR automated …

Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French Uveitis Network

H Vallet, P Seve, L Biard… - Arthritis & …, 2016 - Wiley Online Library
Objective To analyze the factors associated with response to anti–tumor necrosis factor (anti‐TNF)
treatment and compare the efficacy and safety of infliximab (IFX) and adalimumab (…

[HTML][HTML] Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients

…, JE Salem, M Resche Rigon, C Menyssa, L Biard… - PloS one, 2020 - journals.plos.org
Prognostic factors of coronavirus disease 2019 (COVID-19) patients among European
population are lacking. Our objective was to identify early prognostic factors upon admission to …

Association of COVID-19 acute respiratory distress syndrome with symptoms of posttraumatic stress disorder in family members after ICU discharge

…, C Guitton, G Capellier, B Mourvillier, L Biard… - Jama, 2022 - jamanetwork.com
Importance Persistent physical and mental disorders are frequent in survivors of COVID-19–related
acute respiratory distress syndrome (ARDS). However, data on these disorders …

Overall survival and mortality risk factors in Takayasu's arteritis: a multicenter study of 318 patients

A Mirouse, L Biard, C Comarmond, M Lambert… - Journal of …, 2019 - Elsevier
Objective To report the long term mortality in Takayasu arteritis (TA) and to identify prognosis
factors. Methods We analyzed the causes of death and the factors associated with mortality …

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

…, C Nyanou, C Montlahuc, L Biard… - The Lancet …, 2022 - thelancet.com
Background Patients with COVID-19 pneumonia can have increased inflammation and
elevated cytokines, including interleukin (IL)-6, which might be deleterious. Thus, sarilumab, a …

Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis

B Joubert, C Chapelon-Abric, L Biard… - JAMA …, 2017 - jamanetwork.com
Importance Prognostic factors are lacking in neurosarcoidosis (NS), and the association of
immunosuppressive treatments with outcomes are unclear. Objectives To identify prognostic …